Clinical Updates in CSPC

 

Clinical Updates in CSPC
11:07

PROSCA & BLADDR 2023

Treatment Intensification of High-Risk BCR Prostate Cancer

FEATURING Antti Rannikko
  • 86 views
  • January 12, 2024
03:01

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Prognostic Role of Metastatic Site in Patients With De Novo Metastatic Prostate Cancer - A Population-Based Analysis in New Hormonal Agents Era"

FEATURING Emre Yekedüz
  • 67 views
  • January 12, 2024
09:02

Cedars Sinai

Year in Review: EMBARK Study and the Evolving Role of Intensified ADT for Non-Metastatic CSPC

FEATURING Stephen Freedland
  • 250 views
  • January 12, 2024
  • 2
09:51

Insights from 2023 Society of Urologic Oncology Annual Meeting

SUO 2023 Insights: "Doublets or Triplets for Patients With mCSPC - Selecting the Optimal Treatment"

FEATURING Benjamin L. Maughan
  • 182 views
  • December 19, 2023
  • 2
09:19

Insights from 2023 European Multidisciplinary Congress on Urological Cancers

EMUC 2023 Insights: "De-Escalating Strategies in mHSPC - Who, When, How"

FEATURING Bertrand Tombal
  • 117 views
  • December 13, 2023
05:29

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Real-World OS With Enzalutamide & Abiraterone Acetate in Patients With Chemotherapy-Naïve mCRPC"

FEATURING Daniel George
  • 101 views
  • December 5, 2023
11:51

Joshua Lang

Therapeutic Approach in mCSPC: Doublets, Triplets, and Patient Selection

  • 281 views
  • December 1, 2023
  • 2
08:35

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The BonEnza Study - Changes in Bone Mineral Density, Trabecular Bone Score, and Body Composition in mHSPC Patients Randomized to Receive ADT+Enzalutamide+/-Zoledronic Acid"

FEATURING Alberto Dalla Volta
  • 74 views
  • November 28, 2023
  • 1
13:55

Total Health

Case-Based Clinical Updates in Prostate Cancer: 77 y/o Practicing Physician With mCSPC

FEATURING Jingsong Zhang, Juskaran Chadha, Sarah Raymond
  • 98 views
  • October 18, 2023
18:17

International Urology Cancer Summit - IUCS

Treatment Landscape of mHSPC: Doublet or Triplet

FEATURING Neeraj Agarwal
  • 204 views
  • October 13, 2023
  • 3
20:24

Scripps MD Anderson Cancer Center

Metastatic Newly Diagnosed Prostate Cancer: Up-Front Intensification, PARPi + ARPi Combination Therapy, Radioligand Therapy

FEATURING Tanya Barauskas Dorff
  • 163 views
  • August 29, 2023
11:37

Insights from 2023 ASCO® Annual Meeting

Assessment and Decision Tools for Balancing Survival and Quality of Life

FEATURING Elizabeth Kessler
  • 81 views
  • October 3, 2023
04:55

Yale Cancer Center

Post-Hoc Analyses of Phase 3 ARCHES Trial: OS in Patients With mHSPC Who Received Prior ADT and Reached Low PSA Levels Treated Further With Enzalutamide

FEATURING Daniel Petrylak
  • 657 views
  • December 16, 2022
  • 1
42:54

Houston Methodist Hospital

30 Years Perspective on Advanced Prostate Cancer: Using Biology & Perseverance to Conquer New Frontiers

FEATURING Maha Hussain
  • 236 views
  • August 29, 2023
  • 1
12:48

ASCO GU 2023 Conference Coverage

Cost-Effectiveness Analysis of Seven Treatment Regimens in mHSPC: A Public Payer Perspective Using Network Meta-Analysis

FEATURING Manish Kohli
  • 233 views
  • February 28, 2023
  • 1
15:51

Judd Moul

A Multidisciplinary Team Approach to Prostate Cancer

  • 285 views
  • May 9, 2023
11:39

Oncology Data Advisor

Recent Prostate Cancer Updates

FEATURING Ulka Vaishampayan
  • 350 views
  • October 9, 2023
  • 2
04:48

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EMBARK Secondary Endpoints - Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence"

FEATURING Ugo De Giorgi
  • 267 views
  • November 9, 2023
  • 3
10:12

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzalutamide/Placebo + Leuprolide Acetate and Enzalutamide Monotherapy in High-Risk Biochemically Recurrent Prostate Cancer"

FEATURING Stephen Freedland
  • 488 views
  • October 25, 2023
  • 4